Key statistics
On Tuesday, Silo Pharma Inc (SILO:NAQ) closed at 1.05, 24.85% above the 52 week low of 0.841 set on Jul 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.02 |
---|---|
High | 1.08 |
Low | 1.01 |
Bid | 1.03 |
Offer | 1.07 |
Previous close | 1.05 |
Average volume | 50.70k |
---|---|
Shares outstanding | 4.48m |
Free float | 4.30m |
P/E (TTM) | -- |
Market cap | 4.71m USD |
EPS (TTM) | -1.16 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Announcements
- Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD
- Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic
- Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide
- Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference
- Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15
- Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic
- Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders
- Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety
More ▼